
Natera NTRA
€ 175.08
-0.25%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Natera Operativer Cashflow 2011-2026 | NTRA
Operativer Cashflow Jährlich Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -432 M | -335 M | -183 M | -63.4 M | -70.6 M | -97.8 M | -74.1 M | -37.8 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -37.8 M | -432 M | -162 M |
Operativer Cashflow Vierteljährlich Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -137 M | - | - | - | -74.9 M | - | -109 M | -76.1 M | -35.1 M | - | -48.4 M | -35.8 M | -31.8 M | - | -57.8 M | -34.5 M | 1.05 M | - | -69.7 M | -38.4 M | -24.6 M | - | -44.4 M | -20.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.05 M | -137 M | -52.3 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Castle Biosciences
CSTL
|
64.3 M | $ 20.15 | -1.9 % | $ 584 M | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Guardant Health
GH
|
-185 M | $ 118.95 | 0.8 % | $ 14.9 B | ||
|
Fulgent Genetics
FLGT
|
-102 M | $ 17.11 | -1.55 % | $ 517 M | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 116.78 | 0.18 % | $ 9.63 B | ||
|
Agilent Technologies
A
|
1.48 B | $ 114.96 | 0.15 % | $ 34.9 B | ||
|
Celcuity
CELC
|
-153 M | $ 138.23 | -3.02 % | $ 6.46 B | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 5.07 | 36.66 % | $ 6.74 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-24.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 21.63 | 0.28 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-46 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
837 M | $ 144.41 | -0.29 % | $ 23 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.82 | 1.11 % | $ 8.05 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 103.0 | 9.03 % | $ 6.95 B | ||
|
Medpace Holdings
MEDP
|
713 M | $ 432.8 | 0.63 % | $ 12.5 B | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
956 M | $ 1 103.09 | 1.16 % | $ 22.7 B | ||
|
Genetic Technologies Limited
GENE
|
-9.68 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 160.3 | 0.91 % | $ 7.95 B | ||
|
Personalis
PSNL
|
-74.9 M | $ 8.47 | 2.67 % | $ 756 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
5.23 M | $ 9.23 | 1.32 % | $ 1.18 B | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
26.4 M | $ 19.08 | 0.21 % | $ 427 M | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 3.82 | -2.3 % | $ 354 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.34 | 2.92 % | $ 265 M | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 60.57 | 2.95 % | $ 3.62 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.49 | 2.05 % | $ 5.72 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 259.93 | 1.63 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 448.28 | -0.24 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
-4.19 M | $ 0.6 | -3.7 % | $ 216 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 8.9 | 0.45 % | $ 1.93 B | ||
|
Waters Corporation
WAT
|
653 M | $ 342.37 | 0.4 % | $ 20.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.21 | 0.72 % | $ 21.7 B |